Kyverna Therapeutics Inc. (KYTX)
NASDAQ: KYTX
· Real-Time Price · USD
5.52
-0.56 (-9.21%)
At close: Oct 03, 2025, 3:59 PM
5.54
0.36%
After-hours: Oct 03, 2025, 07:59 PM EDT
-9.21% (1D)
| Bid | 5.4 |
| Market Cap | 238.72M |
| Revenue (ttm) | 2.02M |
| Net Income (ttm) | -158.7M |
| EPS (ttm) | -3.68 |
| PE Ratio (ttm) | -1.5 |
| Forward PE | -1.71 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 5.52 |
| Volume | 543,691 |
| Avg. Volume (20D) | 363,623 |
| Open | 6.00 |
| Previous Close | 6.08 |
| Day's Range | 5.46 - 6.25 |
| 52-Week Range | 1.78 - 7.20 |
| Beta | 3.75 |
| Ex-Dividend Date | n/a |
About KYTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol KYTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for KYTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
+13.66%
Kyverna Therapeutics shares are trading higher aft...
Unlock content with
Pro Subscription
